Stay updated on Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial page.

Latest updates to the Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial page
- Check3 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov page, announcing updates to NIH terminology and linking to transition information.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange Detected403 Forbidden error is shown on the study page, replacing the normal study record content and navigation. Users cannot access the CAPItello-291 trial details as a result.SummaryDifference16%

- Check38 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new published revision of the page. This reflects a general update to the page's metadata or UI rather than substantive changes to the study details.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page shows a new revision tag (v3.6.6) replacing the previous (v3.6.5), indicating a small update to the page just in its metadata or formatting. This change does not modify the substantive study details or participation criteria.SummaryDifference0.0%

Stay in the know with updates to Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial page.